50 Participants Needed

Nutrition and Exercise Advice for Prostate Cancer

Age: 18+
Sex: Male
Trial Phase: Academic
Sponsor: Roswell Park Cancer Institute
Must be taking: Androgen deprivation therapy
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how personalized nutrition and exercise plans can help prostate cancer patients on hormone therapy reduce frailty linked to obesity. Participants will receive a tailored diet (dietary intervention), engage in a home exercise program (exercise intervention), and attend monthly educational meetings (educational intervention). The goal is to determine if these interventions can improve overall health and alter blood markers related to muscle health. This trial suits men with prostate cancer who are currently on hormone therapy and can walk unassisted for at least 100 meters (about 200 steps). As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance the quality of life for many.

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these interventions are safe for prostate cancer patients?

Research shows that dietary changes are generally safe for prostate cancer patients. Studies have found that a low-fat diet can slow the growth of prostate cancer cells, with no major side effects reported. Patients in past trials managed these diets well.

Exercise programs that include both aerobic activities (like walking) and resistance exercises (like weight lifting) are also well-received. Research suggests these exercises can improve quality of life and fitness without causing harm, safely reducing the side effects of prostate cancer treatments.

Educational programs, which involve learning about prostate cancer and health, have proven effective without any safety concerns. These programs can increase knowledge and promote healthy habits.

Overall, existing research considers these interventions—diet, exercise, and education—safe for prostate cancer patients.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it's exploring how a combination of diet, exercise, and education can support prostate cancer patients, offering an alternative to traditional treatments like surgery, radiation, or hormone therapy. Unlike conventional approaches that primarily target the cancer cells directly, this method focuses on enhancing overall well-being and potentially improving quality of life. The personalized diet plan, tailored exercise regimen, and monthly educational meetings aim to empower patients to take an active role in their health, which could lead to better outcomes and increased patient satisfaction. This holistic approach could redefine how supportive care is integrated into cancer treatment.

What evidence suggests that these nutrition and exercise interventions could be effective for prostate cancer survivors?

This trial will evaluate the impact of a combined approach involving dietary, exercise, and educational interventions for prostate cancer. Research has shown that dietary changes can help manage prostate cancer by influencing growth factors. One study found that a low-fat diet might slow the growth of prostate cancer cells. For exercise, combining activities like walking or cycling with strength training can enhance the overall well-being and health of men with prostate cancer. Studies also suggest that exercise can boost physical abilities and mental sharpness, which are important during cancer treatment. Educational programs about prostate cancer can help patients understand their condition better, encouraging them to take an active role in their care and decisions, leading to improved health.13467

Who Is on the Research Team?

Gurkamal Chatta MD | Roswell Park ...

Gurkamal Chatta, Dr.

Principal Investigator

Roswell Park Cancer Institute

Are You a Good Fit for This Trial?

This trial is for prostate cancer survivors who are overweight or obese and have been on androgen deprivation therapy for less than 5 years. They must be able to walk, have normal liver function, not be receiving other cancer treatments like chemo, and can't have severe heart or lung conditions.

Inclusion Criteria

Creatinine < 1.5 x upper limit of normal (ULN), AST or ALT <2 x ULN within 6 months prior to enrollment
You have a high body mass index (BMI), indicating that you are overweight or obese.
I have been on hormone therapy for less than 5 years.
See 7 more

Exclusion Criteria

You have certain orthopedic, musculoskeletal or psychological conditions that may limit your participation (decided by the doctor).
Your doctor thinks that you are too weak or frail to participate in the study.
Unwilling or unable to follow protocol requirements
See 4 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive an individualized diet plan and complete a home-based exercise program for 6 months, including aerobic and resistance exercises, and attend monthly educational meetings.

6 months
Monthly educational meetings

Follow-up

Participants are monitored for changes in body composition, muscle strength, and other health metrics after the intervention.

4-8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Dietary Intervention
  • Educational Intervention
  • Exercise Intervention
Trial Overview The study tests if personalized nutrition advice and exercise programs can reduce obesity-related weakness in men treated with hormone therapy for prostate cancer. It also looks at changes in blood levels of muscle-related proteins (myokines).
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Supportive care (diet, exercise, education)Experimental Treatment5 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Roswell Park Cancer Institute

Lead Sponsor

Trials
427
Recruited
40,500+

Published Research Related to This Trial

This study will compare the effectiveness of a telehealth-delivered exercise and nutrition program against a traditional clinic-based program in 104 overweight/obese men with prostate cancer, focusing on reducing fat mass while preserving muscle mass.
The trial aims to demonstrate that a remote intervention can be as effective as in-person supervision, making it more accessible for patients undergoing androgen deprivation therapy, which often leads to increased fat mass.
Weight loss for overweight and obese patients with prostate cancer: a study protocol of a randomised trial comparing clinic-based versus Telehealth delivered EXercise and nutrition intervention (the TelEX trial).Galvão, DA., Taaffe, DR., Hayne, D., et al.[2022]
A pilot study involving 52 men with prostate cancer showed a significant increase in nutrition knowledge after attending a seminar, with scores rising from 71.6% to 79.3%.
Participants found the nutrition education seminar satisfactory and expressed a desire for more integrative approaches to dietary information, suggesting that group education could be a cost-effective method for improving dietary knowledge in cancer care.
Nutrition Education Seminars for Prostate Cancer-Diet and Prostate Program: Evaluation and Recommendations (DAPPER Study).Stringer, EJ., Sidhu, S., Austin, K., et al.[2022]
Only a small percentage of long-term prostate cancer survivors (11.8% using diet and 7.8% using exercise) actively employed dietary changes or exercise to manage their condition, indicating a potential gap in awareness or utilization of these strategies.
Younger, more educated survivors, and those involved in support groups were more likely to adopt these lifestyle changes, suggesting that targeted counseling could enhance the use of diet and exercise to improve quality of life and cancer outcomes.
Factors associated with the use of diet and the use of exercise for prostate cancer by long-term survivors.Hughes, S., Egger, S., Carle, C., et al.[2020]

Citations

Nutrition, dietary interventions and prostate cancerGrowth inhibitory effect of low fat diet on prostate cancer cells: results of a prospective, randomized dietary intervention trial in men with prostate cancer.
Review article The effect of dietary interventions or patterns ...This review synthesizes the evidence on the effect of dietary interventions on cardiometabolic biomarkers and cardiovascular disease risk in prostate cancer ...
Dietary interventions in cancer: a systematic review of all ...In this systematic review, we assessed all randomized controlled trials (RCTs) investigating dietary interventions for cancer patients.
4.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/38973750/
a target trial emulation in the Health Professionals Follow-up ...We emulated a target trial of recommendation-based physical activity and dietary strategies and 26-year risks of prostate cancer, adjusting for risk factors ...
Effect of a Behavioral Intervention to Increase Vegetable ...A behavioral intervention that increased vegetable consumption did not significantly reduce the risk of prostate cancer progression among men with early-stage ...
Dietary Patterns in Prostate Cancer Prevention and ...Our review suggests that plant-based and healthy dietary patterns are associated with lower PC risks that are more obvious for progression than ...
Nutrition and Diet in the Prevention and Management of ...This study aims to analyze global scientific evidence regarding the role of diet in the prevention and management of prostate cancer.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security